Edgewise Therapeutics (EWTX) Stock: Latest News, Analyst Forecasts, and What’s Driving the December 2025 Surge

Edgewise Therapeutics (EWTX) Stock: Latest News, Analyst Forecasts, and What’s Driving the December 2025 Surge

Edgewise Therapeutics, Inc. (Nasdaq: EWTX) is ending mid-December 2025 in classic clinical-stage biotech fashion: big percentage swings, a sharp momentum breakout, and investors trying to decide whether the move is “new information” or simply “new positioning.” As of Saturday, December
Amicus Therapeutics Stock (FOLD) Surges as BioMarin Agrees to Buy the Rare-Disease Biotech for $4.8 Billion

Amicus Therapeutics Stock (FOLD) Surges as BioMarin Agrees to Buy the Rare-Disease Biotech for $4.8 Billion

December 20, 2025 — Amicus Therapeutics, Inc. (NASDAQ: FOLD) is suddenly trading like a classic merger-arbitrage stock after BioMarin Pharmaceutical (NASDAQ: BMRN) agreed to acquire the company in an all-cash deal valued at roughly $4.8 billion. BioMarin’s offer of $14.50
Firefly Aerospace Stock (NASDAQ: FLY) News Today — Dec. 20, 2025: Why Shares Jumped, Analyst Forecasts, SEC Filings, and the Lawsuit Clock

Firefly Aerospace Stock (NASDAQ: FLY) News Today — Dec. 20, 2025: Why Shares Jumped, Analyst Forecasts, SEC Filings, and the Lawsuit Clock

Firefly Aerospace Inc. (NASDAQ: FLY) is back in the spotlight as of Saturday, December 20, 2025—not because markets are open today (they aren’t), but because Friday’s session (Dec. 19) delivered the kind of price action that turns a newly public
Comfort Systems USA (FIX) Stock News Today: Leadership Transition, S&P 500 Addition, Analyst Targets, and 2026 Outlook (Dec. 20, 2025)

Comfort Systems USA (FIX) Stock News Today: Leadership Transition, S&P 500 Addition, Analyst Targets, and 2026 Outlook (Dec. 20, 2025)

Comfort Systems USA, Inc. (NYSE: FIX) heads into the final full week of 2025 with two headline catalysts in focus: a year-end leadership transition and a pending move into the S&P 500—both of which are shaping weekend headlines, analyst commentary,
Go toTop